or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 47 Medicine PhD Projects, Programmes & Scholarships for Self-funded Students in Bradford
Medicine PhD Projects, Programmes & Scholarships for Self-funded Students in Bradford
We have 47 Medicine PhD Projects, Programmes & Scholarships for Self-funded Students in Bradford
Reviewing and optimising the use of electronic prescribing systems to improve medicine safety in integrated care systems
Research Group:
Health Technologies
With a rapidly ageing population in the UK, there is an escalating demand for older care that requires therapeutic drug monitoring with the help of electronic prescribing and record systems (EPRS). Read more
Cancer: Why and how do brain tumour cells invade ‘mini-brains’?
Globally, nearly 189,000 people die each year as a result of brain cancer and around 250,000 people are diagnosed with a malignant brain tumour (umbrella name. Read more
Inequality of timely Clostridioidies difficile infection testing, treatment and management in hospitalised and community patients
As part of the National Institute for Health Research funded, Leeds Biomedical Research Centre (BRC), one PhD scholarship is available for UK fee rated applicants only. Read more
Advanced analytics to investigate novel BP wearable technology to improve cardiovascular outcomes and falls
This is a unique opportunity to work with the world’s largest research cohort of its kind harnessing detailed 24-hour blood pressure records and cardiovascular and falls outcomes on follow up for more than 26,000 people across three UK City regions. Read more
Genetics: Investigating the functional effect of novel genes and genetic variants in malignant hyperthermia susceptibility using model systems
Malignant hyperthermia (MH) is an inherited condition, where patients exposed to anaesthetic drugs are susceptible to a dramatic hyperthermic and hypermetabolic response that can contribute to a significant proportion of post-operative morbidity and deaths. Read more
Cancer: Investigation of accentuated mitochondrial ROS and NLRP3 inflammasome activation in cystic fibrosis and colorectal carcinoma.
Cystic fibrosis (CF) is associated with an accentuated inflammatory response to bacterial lipopolysaccharides (LPS), increased resting energy expenditure and a higher than expected prevalence of gastrointestinal and other malignancies. Read more
Clinical: Gastroesophageal reflux in respiratory disease: pathogenic role and improved management
Gastroesophageal reflux disease (GERD) is a condition in which stomach contents, such as food and acid pass into the gullet/oesophagus causing heartburn. GERD is very common in patients with lung disease, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Read more
Integrated omics approach to psychiatric disorders
Research Group:
Chemistry and Biosciences
In psychiatry, the selection of antipsychotics and antidepressants is led by a trial-and-error approach. The prescribing of these medications is complicated by sub-optimal efficacy and high rates of adverse drug reactions (ADRs). Read more
Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products
Research Group:
Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more
Therapeutic resolution of Myelodysplastic Syndrome (MDS) by natural products
Research Group:
Pharmacology and Experimental Therapeutics
Myelodysplastic syndromes (MDS) are a type of blood cancer where the patients do not have enough healthy blood cells. Read more
Therapeutic resolution of coronavirus (COVID-19) diseases by natural products
Research Group:
Pharmacology and Experimental Therapeutics
Coronavirus now labelled as Covid-19 has become a global pandemic affecting around 200 countries. Currently neither any cure nor any vaccine for Covid-19 has been established. Read more
Development of a personalized therapy for pulmonary arterial hypertension (PAH)
Research Group:
Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more
Re-purposing established drugs for the resolution of pulmonary arterial hypertension (PAH)
Research Group:
Pharmacology and Experimental Therapeutics
Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death. Read more
Formulation and biopharmaceutical characterisation of novel pro-antibiotics for improved oral permeability
Research Group:
Pharmacology and Experimental Therapeutics
This project is focused on the formulation, synthesis, and biopharmaceutical characterisation of novel pro-antibiotics for improved oral bioavailability. . Read more
Molecular mechanisms of pacemaker (sinus node) dysfunction in ageing, heart failure and athletes
Research Group:
Chemistry and Biosciences
The heart’s pacemaker, the sinus node, initiates the action potential that causes the heart to beat, and the atrioventricular node conducts the action potential from the atria to the ventricles, the pumping chambers of the heart. Read more